Filing Details
- Accession Number:
- 0001144204-15-011489
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-23 17:33:53
- Reporting Period:
- 2015-02-19
- Filing Date:
- 2015-02-23
- Accepted Time:
- 2015-02-23 17:33:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1372514 | Eyegate Pharmaceuticals Inc | EYEG | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1620376 | S.a.) Partenaires (Innoven Ipsa | 10 Rue De La Paix Paris I0 75002 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-02-19 | 524,998 | $0.00 | 524,998 | No | 4 | C | Indirect | See Footnote |
| Common Stock | Acquisiton | 2015-02-19 | 169,306 | $0.00 | 694,304 | No | 4 | C | Indirect | See Footnote |
| Common Stock | Acquisiton | 2015-02-19 | 261,314 | $0.00 | 955,618 | No | 4 | C | Indirect | See Footnote |
| Common Stock | Acquisiton | 2015-02-19 | 138,194 | $4.20 | 1,093,812 | No | 4 | C | Indirect | See Footnote |
| Common Stock | Acquisiton | 2015-02-19 | 366,667 | $6.00 | 1,460,479 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | See Footnote |
| No | 4 | C | Indirect | See Footnote |
| No | 4 | C | Indirect | See Footnote |
| No | 4 | C | Indirect | See Footnote |
| No | 4 | P | Indirect | See Footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series B Preferred Stock | Disposition | 2015-02-19 | 524,998 | $0.00 | 524,998 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2015-02-19 | 169,306 | $0.00 | 169,306 | $0.00 |
| Common Stock | Series D Preferred Stock | Disposition | 2015-02-19 | 261,314 | $0.00 | 261,314 | $0.00 |
| Common Stock | Convertible Promissory Note | Acquisiton | 2015-02-19 | 0 | $580,415.00 | 138,194 | $4.20 |
| Common Stock | Convertible Promissory Note | Disposition | 2015-02-19 | 0 | $0.00 | 138,194 | $4.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | 2015-02-19 | 2015-06-06 | No | 4 | P | Indirect |
| 0 | 2015-02-19 | 2015-06-06 | No | 4 | C | Indirect |
Footnotes
- Upon closing of the Issuer's initial public offering, each share of Series B Preferred Stock converted automatically into shares of common stock of the Issuer on a 10.94-for-one basis, and had no expiration date.
- Innoven Partenaires S.A. ("IPSA") is the manager of each of Innoven 2002 FCPI No.6, Innoven 2003 FCPI No.7, FCPI Innoven Europe, FCPI Innoven Europe 2, FCPI Innoven Europe 3, FCPI Innoven Capital, FCPI Innoven Capital 2, FCPI Poste Innovation, FCPI Poste Innovation 2, FCPI Poste Innovation 3, FCPI Poste Innovation 5, FCPI Poste Innovation 6, FCPI Poste Innovation 9 and FCPI La Banque Postale Innovation 1 (collectively, the "Funds"). Voting and investment power over the shares held by each of the Funds may be deemed to be shared with IPSA. Each of Jean-Michel Paulhac ("Paulhac") and Thomas Balland ("Balland ") are directors of IPSA. Each of Paulhac and Balland disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein.
- Represents 26,994, 71,111, 16,416, 711,099, 428,115, 599,019, 817,685, 2,203,862, 885,941, and 4,288 shares held by Innoven 2002 FCPI No.6, Innoven 2003 FCPI No.7, FCPI Innoven Europe, FCPI Poste Innovation, FCPI Poste Innovation 2, FCPI Poste Innovation 3, FCPI Poste Innovation 5, FCPI Poste Innovation 6, FCPI Poste Innovation 9, and FCPI La Banque Postale Innovation 1, respectively.
- Upon closing of the Issuer's initial public offering, each share of Series C Preferred Stock converted automatically into shares of common stock of the Issuer on a 9.60-for-one basis, and had no expiration date.
- Represents 324,574, 31,532, 217,235, 89,946, 139,349, 269,507 and 786,837 shares held by FCPI Innoven Europe, FCPI Innoven Europe 2, FCPI Poste Innovation, FCPI Poste Innovation 2, FCPI Poste Innovation 3, FCPI Poste Innovation 5 and FCPI La Banque Postale Innovation 1, respectively.
- Upon closing of the Issuer's initial public offering, each share of Series D Preferred Stock converted automatically into shares of common stock of the Issuer on a 10.96-for-one basis, and had no expiration date.
- Represents 1,163, 527,940, 429,985, 361,720, 84,327, 920,096, 219,702, 219,862, 216 and 104,236 shares held by FCPI Innoven Europe, FCPI Innoven Europe 2, FCPI Innoven Europe 3, FCPI Innoven Capital, FCPI Innoven Capital 2, FCPI Poste Innovation, FCPI Poste Innovation 2, FCPI Poste Innovation 3, and FCPI La Banque Postale Innovation 1, respectively.
- Represents 5,791, 7,865, 31,161, 50,953, 39,160, 32,943, 7,680, 230,238, 149,680, 193,633, 210,214, 200,716, 80,706 and 81,544 shares held by Innoven 2002 FCPI No.6, Innoven 2003 FCPI No.7, FCPI Innoven Europe, FCPI Innoven Europe 2, FCPI Innoven Europe 3, FCPI Innoven Capital, FCPI Innoven Capital 2, FCPI Poste Innovation, FCPI Poste Innovation 2, FCPI Poste Innovation 3, FCPI Poste Innovation 5, FCPI Poste Innovation 6, FCPI Poste Innovation 9 and FCPI La Banque Postale Innovation 1, respectively.
- Represents 5,791, 10,006, 36,191, 64,167, 39,160, 32,943, 15,230, 230,238, 149,680, 193,633, 280,566, 231,074, 80,706 and 91,103 shares held by Innoven 2002 FCPI No.6, Innoven 2003 FCPI No.7, FCPI Innoven Europe, FCPI Innoven Europe 2, FCPI Innoven Europe 3, FCPI Innoven Capital, FCPI Innoven Capital 2, FCPI Poste Innovation, FCPI Poste Innovation 2, FCPI Poste Innovation 3, FCPI Poste Innovation 5, FCPI Poste Innovation 6, FCPI Poste Innovation 9 and FCPI La Banque Postale Innovation 1, respectively.
- Represents 2,141, 5,030, 13,214, 7,550, 70,342, 30,358 and 9,559 shares held by Innoven 2003 FCPI No.7, FCPI Innoven Europe, FCPI Innoven Europe 2, FCPI Innoven Capital 2, FCPI Poste Innovation 5, FCPI Poste Innovation 6 and FCPI La Banque Postale Innovation 1, respectively.
Billionaire Hedge Funds
